Filing Flows › Serina Therapeutics (SER) › Recalls, complaints & regulation
Serina Therapeutics (SER): clinical trials
Serina Therapeutics (SER) beyond its filings: 1 active clinical trial.
Serina Therapeutics' latest quarter
Serina Therapeutics, Q2 2025: revenue $130K (+155% year over year), net loss $6.5M, operating cash flow −$3.8M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Serina Therapeutics have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.